Copyright
©The Author(s) 2015.
World J Gastrointest Pharmacol Ther. Nov 6, 2015; 6(4): 183-198
Published online Nov 6, 2015. doi: 10.4292/wjgpt.v6.i4.183
Published online Nov 6, 2015. doi: 10.4292/wjgpt.v6.i4.183
Table 3 Helicobacter pylori eradication rates following first-line concomitant therapy
Country | Ref. | Publication | Treatment duration | Patients | Therapy regimen | Eradication rate (ITT) | Eradication rate (PP) |
South Korea | Lim et al[104] | 2013 | 14 d | 78 | Rab 20 mg bid | 80.8% | 81.3% |
Amo 1 g bid | |||||||
Cla 500 mg bid | |||||||
Met 500 mg bid | |||||||
Lee et al[100] | 2015 | 7 d | 170 | Rab 20 mg bid | 79.4% | 94.4% | |
Amo 1 g bid | |||||||
Cla 500 mg bid | |||||||
Met 500 mg tid | |||||||
Thailand | Kongchayanun et al[188] | 2012 | 5 d/10 d | 55/55 | Rab 20 mg bid | 89.1%/96.4% | NA |
Amo 1 g bid | |||||||
Met 400 mg tid | |||||||
Cla 1 g qd | |||||||
Singapore | Ang et al[102] | 2015 | 10 d | 153 | PPI standard does | 81.7% | 95.4% |
Amo 1 g bid | |||||||
Cla 500 mg bid | |||||||
Met 400 mg bid | |||||||
Spain | Molina-Infante et al[97] | 2012 | 10 d | 209 | PPI standard does | 87.0% | 89.0% |
Amo 1 g bid | |||||||
Cla 500 mg bid | |||||||
Met 500 mg bid | |||||||
McNicholl et al[103] | 2014 | 10 d | 168 | Ome 20 mg bid | 87.0% | 91.0% | |
Amo 1 g bid | |||||||
Cla 500 mg bid | |||||||
Met 500 mg bid | |||||||
Latin America | Greenberg et al[106] | 2011 | 5 d | 489 | Lan 30 mg bid | 73.6% | NA |
Amo 1 g bid | |||||||
Cla 500 mg bid | |||||||
Met 500 mg bid |
-
Citation: Kim SY, Choi DJ, Chung JW. Antibiotic treatment for
Helicobacter pylori : Is the end coming? World J Gastrointest Pharmacol Ther 2015; 6(4): 183-198 - URL: https://www.wjgnet.com/2150-5349/full/v6/i4/183.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v6.i4.183